Sensitive ASX Announcement

Acrux to proceed with AXIRON NDA following meeting with FDA

Published: 03/09/09, 10:17am (AEST)4 pages
Acrux Limited
ACR:ASXHealthcare

Recent ACR Announcements

Price Sensitive only